Galmed Pharma (GLMD) Reports Q4 Loss of $0.40/Share

Galmed Pharma (NASDAQ: GLMD) reported Q4 EPS of ($0.40), versus ($0.29) reported last year.

For earnings history and earnings-related data on Galmed Pharma (GLMD) click here.

You May Also Be Interested In

• Korn Ferry (KFY) Tops Q4 EPS by 2c, Beats on Revenue; Offers Q1 Guidance
• Synopsys upgraded at Piper Sandler on Intel foundry momentum, Apple opportunity
• Bernstein SocGen Group Reiterates Outperform Rating on Hermes International (RMS:FP) (HESAY) after cautious commentary